Murata Manufacturing Future Growth
Future criteria checks 2/6
Murata Manufacturing is forecast to grow earnings and revenue by 16.3% and 6.2% per annum respectively. EPS is expected to grow by 16.4% per annum. Return on equity is forecast to be 12.4% in 3 years.
Key information
16.3%
Earnings growth rate
16.4%
EPS growth rate
Electronic earnings growth | 18.1% |
Revenue growth rate | 6.2% |
Future return on equity | 12.4% |
Analyst coverage | Good |
Last updated | 08 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 2,019,581 | 333,786 | 325,775 | 483,655 | 15 |
3/31/2026 | 1,895,259 | 308,103 | 278,244 | 452,314 | 17 |
3/31/2025 | 1,764,857 | 262,214 | 229,307 | 419,307 | 17 |
9/30/2024 | 1,713,289 | 186,005 | 306,035 | 513,995 | N/A |
6/30/2024 | 1,694,171 | 197,105 | 267,172 | 488,756 | N/A |
3/31/2024 | 1,640,158 | 180,835 | 253,409 | 489,637 | N/A |
12/31/2023 | 1,597,338 | 216,374 | 181,152 | 419,198 | N/A |
9/30/2023 | 1,576,922 | 218,483 | 83,438 | 314,619 | N/A |
6/30/2023 | 1,617,833 | 228,582 | 82,153 | 304,312 | N/A |
3/31/2023 | 1,686,796 | 253,685 | 86,327 | 276,278 | N/A |
12/31/2022 | 1,772,262 | 275,509 | 114,376 | 292,758 | N/A |
9/30/2022 | 1,824,671 | 306,687 | 209,490 | 366,857 | N/A |
6/30/2022 | 1,809,621 | 312,102 | 249,056 | 394,690 | N/A |
3/31/2022 | 1,812,521 | 314,119 | 270,927 | 421,458 | N/A |
12/31/2021 | 1,789,001 | 311,167 | 314,685 | 487,584 | N/A |
9/30/2021 | 1,786,262 | 304,981 | 279,513 | 467,498 | N/A |
6/30/2021 | 1,742,952 | 274,688 | 187,210 | 386,085 | N/A |
3/31/2021 | 1,630,193 | 237,053 | 173,695 | 373,571 | N/A |
12/31/2020 | 1,583,538 | 212,552 | 75,039 | 327,004 | N/A |
9/30/2020 | 1,525,112 | 192,140 | 65,305 | 328,262 | N/A |
6/30/2020 | 1,503,287 | 175,766 | 65,372 | 346,128 | N/A |
3/31/2020 | 1,534,045 | 183,008 | 64,399 | 350,334 | N/A |
12/31/2019 | 1,530,178 | 185,294 | 89,297 | 327,835 | N/A |
9/30/2019 | 1,547,570 | 189,351 | 71,773 | 321,779 | N/A |
6/30/2019 | 1,587,074 | 214,767 | 7,194 | 273,999 | N/A |
3/31/2019 | 1,575,026 | 206,926 | -11,739 | 279,842 | N/A |
12/31/2018 | 1,554,705 | 194,000 | -43,622 | 269,405 | N/A |
9/30/2018 | 1,540,614 | 163,313 | -117,230 | 213,004 | N/A |
6/30/2018 | 1,442,386 | 151,930 | N/A | 221,476 | N/A |
3/31/2018 | 1,371,842 | 146,083 | N/A | 225,249 | N/A |
12/31/2017 | 1,302,735 | 149,563 | N/A | 220,635 | N/A |
9/30/2017 | 1,193,226 | 162,430 | N/A | 255,257 | N/A |
6/30/2017 | 1,149,563 | 151,521 | N/A | 278,996 | N/A |
3/31/2017 | 1,135,524 | 156,060 | N/A | 243,920 | N/A |
12/31/2016 | 1,127,288 | 154,631 | N/A | 295,363 | N/A |
9/30/2016 | 1,162,952 | 173,111 | N/A | 260,651 | N/A |
6/30/2016 | 1,190,938 | 194,891 | N/A | 253,801 | N/A |
3/31/2016 | 1,210,841 | 203,776 | N/A | 252,451 | N/A |
12/31/2015 | 1,215,315 | 212,637 | N/A | 226,445 | N/A |
9/30/2015 | 1,176,766 | 214,562 | N/A | 260,853 | N/A |
6/30/2015 | 1,106,382 | 187,343 | N/A | 254,184 | N/A |
3/31/2015 | 1,043,542 | 167,711 | N/A | 259,936 | N/A |
12/31/2014 | 975,468 | 149,745 | N/A | 226,842 | N/A |
9/30/2014 | 909,170 | 114,057 | N/A | 198,785 | N/A |
6/30/2014 | 872,123 | 102,638 | N/A | 178,687 | N/A |
3/31/2014 | 846,716 | 93,191 | N/A | 185,751 | N/A |
12/31/2013 | 823,110 | 85,633 | N/A | 170,689 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MRAA.Y's forecast earnings growth (16.3% per year) is above the savings rate (2.6%).
Earnings vs Market: MRAA.Y's earnings (16.3% per year) are forecast to grow faster than the US market (15.4% per year).
High Growth Earnings: MRAA.Y's earnings are forecast to grow, but not significantly.
Revenue vs Market: MRAA.Y's revenue (6.2% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: MRAA.Y's revenue (6.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MRAA.Y's Return on Equity is forecast to be low in 3 years time (12.4%).